Related Experiment Video
Updated: May 13, 2026

Measuring Caenorhabditis elegans Life Span in 96 Well Microtiter Plates
Published on: March 18, 2011
Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB
William Mair1, Ianessa Morantte, Ana P C Rodrigues
1The Salk Institute for Biological Studies, La Jolla, California 92037, USA.
Abstract:
Activating AMPK or inactivating calcineurin slows ageing in Caenorhabditis elegans and both have been implicated as therapeutic targets for age-related pathology in mammals. However, the direct targets that mediate their effects on longevity remain unclear. In mammals, CREB-regulated transcriptional coactivators (CRTCs) are a family of cofactors involved in diverse physiological processes including energy homeostasis, cancer and endoplasmic reticulum stress. Here we show that both AMPK and calcineurin modulate longevity exclusively through post-translational modification of CRTC-1, the sole C. elegans CRTC. We demonstrate that CRTC-1 is a direct AMPK target, and interacts with the CREB homologue-1 (CRH-1) transcription factor in vivo. The pro-longevity effects of activating AMPK or deactivating calcineurin decrease CRTC-1 and CRH-1 activity and induce transcriptional responses similar to those of CRH-1 null worms. Downregulation of crtc-1 increases lifespan in a crh-1-dependent manner and directly reducing crh-1 expression increases longevity, substantiating a role for CRTCs and CREB in ageing. Together, these findings indicate a novel role for CRTCs and CREB in determining lifespan downstream of AMPK and calcineurin, and illustrate the molecular mechanisms by which an evolutionarily conserved pathway responds to low energy to increase longevity.
Insights
Activating AMPK or inactivating calcineurin extends lifespan by modifying CRTC-1, a protein crucial for longevity. This pathway involves CRTC-1 and CRH-1, offering new therapeutic targets for age-related diseases.
Area of Science:
- Molecular Biology
- Genetics
- Aging Research
Background:
- AMPK activation and calcineurin inactivation are known to slow aging in C. elegans.
- These pathways are implicated as therapeutic targets for age-related diseases in mammals.
- The direct molecular targets mediating these longevity effects remain largely unknown.
Purpose of the Study:
- To identify the direct targets of AMPK and calcineurin that regulate longevity.
- To elucidate the molecular mechanisms by which these pathways influence lifespan.
- To investigate the role of CREB-regulated transcriptional coactivators (CRTCs) in aging.
Main Methods:
- Utilized C. elegans as a model organism.
- Investigated the interaction between AMPK, calcineurin, CRTC-1, and CRH-1.
- Analyzed transcriptional responses and lifespan modifications through gene manipulation (downregulation).
Main Results:
- AMPK and calcineurin modulate longevity exclusively via post-translational modification of CRTC-1.
- CRTC-1 is a direct AMPK target and interacts with the transcription factor CRH-1.
- Reduced CRTC-1 or CRH-1 activity mimics the pro-longevity effects of AMPK activation or calcineurin inactivation.
Conclusions:
- CRTC-1 and CRH-1 play a novel, critical role in determining lifespan downstream of AMPK and calcineurin.
- This conserved pathway illustrates how low energy signals can increase longevity.
- Findings suggest CRTCs and CREB as potential therapeutic targets for aging and age-related pathologies.
Related Concept Videos
Intracellular Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Global Regulatory Systems

